Altace and Infusion site extravasation - a phase IV clinical study of FDA data


Infusion site extravasation is reported only by a few people who take Altace.

The phase IV clinical study analyzes which people take Altace and have Infusion site extravasation. It is created by eHealthMe based on reports of 22,516 people who have side effects while taking Altace from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 01, 2022

22,516 people reported to have side effects when taking Altace.
Among them, 4 people (0.02%) have Infusion site extravasation.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,106 Altace users for its effectiveness, alternative drugs and more.

What is Infusion site extravasation?

Infusion site extravasation (flow of (blood or lymph) from infusion site) is found to be associated with 835 drugs and 442 conditions by eHealthMe.

Number of Altace and Infusion site extravasation reports submitted per year:

Could Altace cause Infusion site extravasation?

Gender of people who have Infusion site extravasation when taking Altace *:

  • female: 50 %
  • male: 50 %

Age of people who have Infusion site extravasation when taking Altace *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Altace *:

  1. Visudyne: 1 person, 25.00%
  2. Treanda: 1 person, 25.00%
  3. Rituxan: 1 person, 25.00%
  4. Risedronate Sodium: 1 person, 25.00%
  5. Prednisone: 1 person, 25.00%
  6. Orencia: 1 person, 25.00%
  7. Lovastatin: 1 person, 25.00%
  8. Lasix: 1 person, 25.00%
  9. Glimepiride: 1 person, 25.00%
  10. Cymbalta: 1 person, 25.00%

Common side effects people have besides Infusion site extravasation *:

  1. Rashes (redness): 2 people, 50.00%
  2. Pneumonia: 2 people, 50.00%
  3. The Flu (the flu is caused by an influenza virus): 1 person, 25.00%
  4. Local Swelling (swelling at the site of some application of substance or injury): 1 person, 25.00%
  5. Burns Third Degree: 1 person, 25.00%
  6. Cough: 1 person, 25.00%
  7. Fall: 1 person, 25.00%
  8. Impaired Driving Ability: 1 person, 25.00%
  9. Impaired Work Ability: 1 person, 25.00%
  10. Infection: 1 person, 25.00%

Common conditions people have *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 25.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 25.00%
  3. Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 1 person, 25.00%
  4. Diabetes: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and have Infusion site extravasation?

Check whether Infusion site extravasation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Infusion site extravasation and when was it recovered:

Expand to all the drugs that have ingredients of ramipril:

Alternative drugs to, pros and cons of Altace:

Common Altace side effects:

Browse all side effects of Altace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Infusion site extravasation treatments and more:

COVID vaccines that are related to Infusion site extravasation:

Common drugs associated with Infusion site extravasation:

All the drugs that are associated with Infusion site extravasation:

Common conditions associated with Infusion site extravasation:

All the conditions that are associated with Infusion site extravasation:

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Altace) and Altace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: